Clinical Decision Support Systems Pipeline Report Featuring Over 300 Companies/Universities and Product Developments by Stages of Development, Segments, Region and Countries, Regulatory Pa...
Aclarion, Inc. (ACON)
Company Research
Source: Yahoo! Finance
The report includes extensive information on major pipeline products, including product descriptions, licensing, and collaboration details, along with other developmental activities. The report categorizes CDSS products based on their stages of development, from early development phases to those that have been approved or issued, and offers key clinical trial data for ongoing trials specific to these pipeline products. The report also discusses recent developments in the CDSS segment, including technological breakthroughs, regulatory updates, and significant industry movements. Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No Company Logo Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Clinical Decision Support Systems Pipeline Report including Stages of Development, Segment
Show less
Read more
Impact Snapshot
Event Time:
ACON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACON alerts
High impacting Aclarion, Inc. news events
Weekly update
A roundup of the hottest topics
ACON
News
- Aclarion, Inc. (NASDAQ: ACON) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand ViewingAccesswire
- Aclarion, Inc. (NASDAQ: ACON) had its price target lowered by analysts at Ascendiant Capital Markets from $1.50 to $1.30. They now have a "buy" rating on the stock.MarketBeat
- Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash [Yahoo! Finance]Yahoo! Finance
- Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashGlobeNewswire
ACON
Sec Filings
- 12/11/24 - Form S-1
- 12/2/24 - Form DEF
- 11/27/24 - Form 8-K
- ACON's page on the SEC website